| Condition | Key Finding | Association | Board Exam Tip |
| Phenylketonuria (PKU) | Mousey/Musty odor; elevated Phe | PAH deficiency | Requires dietary restriction of phenylalanine in infancy. |
| Alkaptonuria | Blue-black urine; Ochronosis | Homogentisic acid oxidase deficiency | The deposition process is key for diagnosis. |
| Porphyria Cutanea Tarda (PCT) | Photosensitivity, Hirsutism | UROD deficiency | Remember the "Tard" association with photosensitivity and Hep C risk. |
| Hemochromatosis | Iron overload; Liver cirrhosis | HFE mutation | Treatment is phlebotomy to reduce iron stores. |
| Topic | Key Point | Context | Exam Relevance |
| Urea Cycle | NAG activates CPS1 (Mitochondria) | Detoxification of excess ammonia from protein catabolism. | Know the double location: Mitochondria -> Cytosol. |
| PKU/AA Disorders | PAH deficiency; elevated Phe | Inborn error of metabolism involving aromatic amino acids. | Must remember the specific odor and enzyme defect. |
| Heme Synthesis | ALAS is rate-limiting; inhibited by heme | Biosynthesis pathway for porphyrins required for hemoglobin. | Porphyrias are often triggered by drugs or fasting/stress. |
| Glycolysis Regulation | Glucokinase (high K_M) regulated by GKRP | Glucose uptake in the liver, ensuring proportional glucose clearance. | High K_M means it operates on the linear portion of the curve. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient presents with a mousy odor, intellectual disability, and is diagnosed with elevated plasma phenylalanine. | Phenylketonuria (PKU) | Defective PAH enzyme leads to accumulation of phenylalanine and its metabolites. |
| A young male develops dark urine and severe arthropathy years after initial symptoms, following an exposure to industrial chemicals. | Alkaptonuria | Accumulation of homogentisic acid, which polymerizes and deposits in connective tissues (ochronosis). |
| A patient presents with photosensitive skin lesions, hypertrichosis, and elevated uroporphyrin levels. | Porphyria Cutanea Tarda (PCT) | Caused by UROD deficiency; the buildup of porphyrins is photoactive. |
| A metabolic screen reveals elevated homocysteine and low B12/B6 status in a patient with megaloblastic anemia. | Folate-B12 Deficiency | Both deficiencies impair remethylation, leading to hyperhomocysteinemia and impaired DNA synthesis. |
| A patient has chronic iron overload due to genetic mutation affecting hepcidin regulation. | Hemochromatosis | HFE mutations lead to excessive intestinal absorption of iron, requiring phlebotomy for treatment. |
| A metabolic disorder presents with elevated plasma ammonia levels and requires administration of sodium phenylbutyrate or sodium benzoate. | Hyperammonemia/Urea Cycle Dysfunction | These agents act as nitrogen scavengers (e.g., forming phenylacetylglutamine) to bypass the impaired urea cycle. |
| Key Features | Distinguishing Findings | Next Step |
| Photosensitivity, hypertrichosis, uroporphyrin buildup | PCT (UROD deficiency): Most common; severe photosensitivity. | Avoid UV light and manage underlying triggers (e.g., Hep C). |
| Neuro symptoms, port-wine urine, no photosensitivity | AIP (PBGD deficiency): Affects the enzyme before uroporphyrinogen III formation. | Management is supportive; often related to specific metabolic blocks. |
| Key Features | Distinguishing Findings | Next Step |
| Low K_M, low VMAX; Hexokinase | High K_M, high VMAX; Glucokinase | Hexokinase is found in most tissues (e.g., brain); Glucokinase is specific to the liver. |
| Insulin-dependent translocation of vesicles | GLUT4 transporter | Muscle and adipose tissue uptake mechanism. |
| Condition | Association | Mechanism | Clinical Significance |
| PKU | Phenylalanine hydroxylase (PAH) deficiency | PAH converts Phe to Tyrosine; defect leads to accumulation of toxic metabolites. | Requires lifelong dietary restriction of phenylalanine. |
| Hemochromatosis | HFE gene mutation | Leads to excessive intestinal absorption and retention of iron. | Treatment is phlebotomy; risk of liver cirrhosis/endocrine failure. |
| Porphyria Cutanea Tarda (PCT) | UROD deficiency | Impaired conversion of uroporphyrinogen III -> uroporphyrinogen IV, leading to photoactive buildup. | Severe photosensitivity and hypertrichosis; risk associated with Hep C. |
| Homocystinuria | B6 or B12/Folate deficiency | Impaired remethylation of homocysteine back to methionine. | Causes megaloblastic anemia and vascular complications (e.g., Marfanoid habitus). |
| Term | Definition | Context | Example |
| N-Acetylglutamate (NAG) | Allosteric activator; a derivative of glutamate and acetyl-CoA. | Urea Cycle regulation. | High protein load leads to increased NAG, activating CPS1. |
| Glucokinase Regulatory Protein (GKRP) | Cytoplasmic protein that sequesters Glucokinase (GK). | Glycolysis/Glucose metabolism in the liver. | When bound by F6 P, GKRP inhibits GK; when bound by glucose, it releases GK to function. |
| Megaloblastic Anemia | Macrocytic anemia due to impaired DNA synthesis. | Folate or B12 deficiency. | Characterized by large, immature red blood cells (megaloblasts). |
| Ochronosis | Blue-black deposition of material in connective tissues. | Alkaptonuria. | Caused by the polymerization and deposition of homogentisic acid. |
| Topic | Study Approach | Priority | Resources |
| Metabolic Cycles (Urea, Heme) | Focus on rate-limiting enzymes, cofactors, and double locations. | High | Review the specific enzyme names and their mitochondrial/cytosolic location. |
| Amino Acid Disorders | Use mnemonics for odors (PKU -> mousy); link defects to clinical signs (Alkaptonuria -> blue-black). | Medium-High | Create flowcharts showing the metabolic block and the resulting toxic metabolite. |
| Carbohydrate Metabolism | Understand allosteric regulation (e.g., GKRP, PFK/F2,6 P) and transporter kinetics (K_M). | High | Practice drawing the regulatory steps for glycolysis in liver vs. muscle. |
🚫Confusing the roles of \text{B}_6 and \text{B}_{12} deficiency: Both cause hyperhomocysteinemia, but \text{B}_6 is needed for transsulfuration (cystathionine synthesis), while \text{B}_{12} is needed for remethylation.